Greenleaf Trust’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,064
| Closed | -$383K | – | 889 |
|
|
2026
Q1 | $383K | Sell |
5,064
-432
| -8% | -$32.5K | ﹤0.01% | 566 |
|
|
2025
Q4 | $409K | Buy |
5,496
+1,596
| +41% | +$117K | ﹤0.01% | 557 |
|
|
2025
Q3 | $263K | Buy |
3,900
+321
| +9% | +$21.3K | ﹤0.01% | 689 |
|
|
2025
Q2 | $233K | Buy |
3,579
+173
| +5% | +$10.4K | ﹤0.01% | 718 |
|
|
2025
Q1 | $210K | Sell |
3,406
-1,192
| -26% | -$79K | ﹤0.01% | 756 |
|
|
2024
Q4 | $331K | Sell |
4,598
-184
| -4% | -$14.4K | ﹤0.01% | 622 |
|
|
2024
Q3 | $390K | Buy |
4,782
+78
| +2% | +$6.24K | ﹤0.01% | 578 |
|
|
2024
Q2 | $349K | Sell |
4,704
-797
| -14% | -$59.7K | ﹤0.01% | 572 |
|
|
2024
Q1 | $429K | Buy |
5,501
+354
| +7% | +$26.3K | ﹤0.01% | 515 |
|
|
2023
Q4 | $368K | Buy |
5,147
+623
| +14% | +$43.4K | ﹤0.01% | 544 |
|
|
2023
Q3 | $314K | Sell |
4,524
-164
| -3% | -$12.4K | ﹤0.01% | 561 |
|
|
2023
Q2 | $380K | Buy |
4,688
+43
| +0.9% | +$3.51K | ﹤0.01% | 523 |
|
|
2023
Q1 | $375K | Buy |
4,645
+371
| +9% | +$29.9K | ﹤0.01% | 533 |
|
|
2022
Q4 | $320K | Buy |
4,274
+385
| +10% | +$27.4K | ﹤0.01% | 563 |
|
|
2022
Q3 | $251K | Sell |
3,889
-162
| -4% | -$11.2K | ﹤0.01% | 598 |
|
|
2022
Q2 | $281K | Sell |
4,051
-2
| -0% | -$148 | ﹤0.01% | 570 |
|
|
2022
Q1 | $311K | Buy |
4,053
+382
| +10% | +$27.5K | ﹤0.01% | 580 |
|
|
2021
Q4 | $281K | Sell |
3,671
-811
| -18% | -$59.6K | ﹤0.01% | 621 |
|
|
2021
Q3 | $331K | Buy |
4,482
+1,363
| +44% | +$102K | ﹤0.01% | 541 |
|
|
2021
Q2 | $208K | Sell |
3,119
-208
| -6% | -$13.9K | ﹤0.01% | 696 |
|
|
2021
Q1 | $247K | Buy |
3,327
+69
| +2% | +$5.24K | ﹤0.01% | 619 |
|
|
2020
Q4 | $237K | Buy |
3,258
+234
| +8% | +$16.5K | ﹤0.01% | 543 |
|
|
2020
Q3 | $201K | Buy |
+3,024
| New | +$191K | ﹤0.01% | 523 |
|
|
2019
Q3 | – | Sell |
-4,237
| Closed | -$203K | – | 571 |
|
|
2019
Q2 | $203K | Sell |
4,237
-607
| -13% | -$28.1K | ﹤0.01% | 507 |
|
|
2019
Q1 | $234K | Sell |
4,844
-100,722
| -95% | -$4.54M | ﹤0.01% | 453 |
|
|
2018
Q4 | $4.34M | Sell |
105,566
-15,351
| -13% | -$630K | 0.09% | 54 |
|
|
2018
Q3 | $4.96M | Buy |
120,917
+4,514
| +4% | +$182K | 0.09% | 54 |
|
|
2018
Q2 | $4.63M | Buy |
116,403
+1,813
| +2% | +$69.7K | 0.09% | 56 |
|
|
2018
Q1 | $4.28M | Buy |
114,590
+2,489
| +2% | +$101K | 0.09% | 61 |
|
|
2017
Q4 | $4.79M | Buy |
112,101
+1,675
| +2% | +$66.8K | 0.1% | 56 |
|
|
2017
Q3 | $4.05M | Buy |
110,426
+9,695
| +10% | +$391K | 0.09% | 60 |
|
|
2017
Q2 | $4.57M | Buy |
+100,731
| New | +$4.45M | 0.1% | 55 |
|
Other funds holding HOLX
Greenleaf Trust's HOLX Position: Q2 2026 in Review
Greenleaf Trust sold out of Hologic (HOLX) in Q2 2026, closing a stake of 5,064 shares — an estimated $383K sold.
Greenleaf Trust first reported a position in HOLX in Q2 2017 and held it in 32 quarters. The position peaked at $4.96M in Q3 2018. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Greenleaf Trust reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Greenleaf Trust sold 5,064 Hologic shares in Q2 2026, an estimated $383K.
- Greenleaf Trust first reported a position in Hologic in Q2 2017 and held it in 32 quarters.
- Greenleaf Trust's Hologic position peaked at $4.96M in Q3 2018.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.